A targeted cancer drug has been approved to treat some people with breast cancer that has a high-risk of returning.
Hope for patients with early-stage lung cancer as new treatment approved for use on NHS England.
In the last decade, many more cancer drugs have become available compared to what we’ve seen previously. This has led to more cancer treatment options, but it has also led to more uncertainty about drugs’ clinical benefit and cost-effectiveness. How can this be addressed?